Pharma Journalist, Author at Pharma Journalist - Page 578 of 880

Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars

Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure

Regulatory and Policy Keynote Sessions to be Delivered at the Wearable Injectors and Connected Devices Conference

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

iBio Inks 3D Bioprinting Agreement

Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893

Juvenescence closes $100m series B round for longevity therapies

Nabriva Therapeutics Receives FDA Approval of Xenleta (lefamulin) to Treat CABP

Mateon and PointR to merge into AI-driven oncology firm

Sarepta Therapeutics Receives Complete Response Letter from the FDA for Golodirsen New Drug Application